Pharmafile Logo

Being Rare Together: Medscape Education Sponsors the 2025 Cholestatic Liver Disease Summit

- PMLiVE

Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in partnership with Children’s Hospital Colorado, a national leader in cholestatic liver disease treatment and research, this summit represents a powerful step forward for families, clinicians, researchers, and advocates actively working to improve the lives of those affected by rare liver conditions.

This first-of-its-kind event brings together a diverse community focused on rare cholestatic liver diseases. Over three days, the summit will include a Scientific Meeting, Research Roundtable, and a Patient & Family Conference, designed to foster collaboration across disciplines and improve care for rare liver disease communities.

Medscape Education’s sponsorship reflects our deep commitment to supporting underserved and complex disease areas through trusted, evidence-based education. We are especially honored to collaborate with key advocacy organizations, such as the Alagille Syndrome Alliance (ALGSA), Biliary Atresia Research and Education (BARE), and the PFIC Advocacy & Resource Network, Inc., whose efforts continue to drive awareness, research, and hope across these rare conditions.

Rare liver diseases often take 6 to 8 years to be accurately diagnosed. Through education, we aim to help shorten this journey. To support ongoing learning and clinical excellence in rare diseases, we have developed a dedicated learning center for healthcare professionals, created in collaboration with rare disease organizations and leading experts. Our Pathways in Rare Disease initiative is designed to help clinicians recognize the early signs of rare diseases and apply the latest insights in diagnosis and management in clinical practice.

This Summit offers a unique opportunity to bring scientists, clinicians, industry, patients, and families together to bridge knowledge gaps, accelerate research, and build a future of High Hopes for those impacted by cholestatic liver disease. Medscape Education is proud to stand alongside this community as we work together to transform rare disease care through knowledge, compassion, and collaboration.

For more information on this collaboration and future rare disease education, please contact Jennifer Bomberger.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

The Power of Patient Insights to Improve Cancer Care

Two global patient advocacy groups—The Lymphoma Coalition and Lung Cancer Europe— are compiling data from their communities on the real-world experience of living with cancer. What the data reveals sometimes...

Medscape Education Continues Its Patient-Centric Mission at EHA 2024

Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape...

Getting in-sync with Public Health at SYNC 2024

Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...

Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care

Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars to improve anemia-related...

Medscape Brings Impact and Data to ESPGHAN

The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...

Empowering Nurses Through Education

Nurse education is powerful and makes an impact.

Pioneering Paths: Women Leadership in Rare Disease

Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...

TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH

It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...

Why Women in Medicine Should Embrace Social Media

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...

Exceptional Impact Presented at ECCMID 2024

The ECCMID conference in Barcelona, Spain marked the start of Medscape’s publication season in Europe. With three posters being presented at the conference, Medscape shared highlights from the powerful impact...